# Effect of Inhaled Fentanyl on Dyspnea and Exercise Tolerance in Chronic Obstructive Pulmonary Disease (COPD)

> **NCT00974220** · NA · COMPLETED · sponsor: **Queen's University** · enrollment: 16 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** fentanyl
- **DRUG:** normal saline (placebo)

## Key facts

- **NCT ID:** NCT00974220
- **Lead sponsor:** Queen's University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2019-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00974220

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00974220, "Effect of Inhaled Fentanyl on Dyspnea and Exercise Tolerance in Chronic Obstructive Pulmonary Disease (COPD)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00974220. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*